GENE ONLINE|News &
Opinion
Blog

2022-01-15| In-depthSpecial

Recent Advances in Breast Cancer Treatments: An Overview

by GeneOnline
Share To
Breast cancer has the second high prevalence among all types of cancer in the US. The average risk of a woman developing it and dying from the disease stands at 13% and 2.6%, making it the second leading cause of cancer death in women.

Breast cancer subtypes are defined by their histopathological appearance and expression of hormone receptors (HR) and growth factors, including estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2).

Recent advances in breast cancer treatments provide more approaches to improve the progression-free survival and overall survival rates in patients; developing new agents and strategies can improve drug resistance and efficacy in current treatment. Breast cancer treatments are majorly decided by the cancer stage, subtype, patient's overall health, menopause status, and cancer growth rate.

GO Prime with only $1.49 now

LATEST
Flagship-Backed ProFound Launches With $75 Million to Discover Human Proteins
2022-05-27
Janssen’s First Cell Therapy Gets Europe’s Approval for Multiple Myeloma
2022-05-27
Cell and Gene Therapy Landscape in Japan is Moving Beyond Oncology
2022-05-27
New Study Reveals Hope for Recovery of Patients with Spinal Cord Injury
2022-05-27
Laekna Therapeutics Announces Dosing of First Patients in the U.S. and China in Phase Ib/III Study of Afuresertib in Combination with Fulvestrant in HR+/HER2- Breast Cancer
2022-05-26
Stanford Touts Remote-Controllable CAR-T Cell Therapy
2022-05-26
Phenomix Launches The First Obesity Biobank Registry To Study Underling Phenotypes
2022-05-26
EVENT
2022-06-03
ASCO Annual Meeting
Online and on-side
2022-06-07
Digital RESI June
Online
2022-06-09
Medhospafrica
Africa
2022-06-13
BIO International Convention
San Diego, CA
2022-12-14
BIOHK2022
Hong Kong, China
Scroll to Top

Create an account with us now to say goodbye to all the pop-ups!